A Prospective Phase II Efficacy and Safety Study of Anlotinib in Metastatic or Locally Advanced Pheochromocytoma/ Paraganglioma : Open-label Single-arm, Exploratory Trial
Clinical trial NCT05133349 · UNKNOWN
Trial details
- NCT number
- NCT05133349
- Sponsor
- Nanjing First Hospital, Nanjing Medical University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-14
- Primary completion
- 2023-09-14
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.